When it comes to cannabis and schizophrenia, the conversation usually leans toward warnings and worst-case scenarios.
For years, headlines have shouted about links between cannabis use and psychosis, making it seem like any legalisation effort is a direct threat to mental health.
But what if that’s not the whole story?
A major new study out of Ontario, Canada, suggests something surprising: cannabis legalisation might actually reduce acute mental health crises among people with schizophrenia. Particularly when appropriate regulations are in place.
Let’s break it down.
What This New Study Found
The study, published in The Canadian Journal of Psychiatry (PubMed ID: 39387895), looked at 121,061 adults diagnosed with schizophrenia in Ontario between October 2015 and May 2021.
Researchers analysed emergency department (ED) visits related to cannabis use, mental health, and substance use before and after cannabis was legalised for adult use. Importantly, they split legalisation into two phases:
- Phase 1: Legalisation of dried flower and herb (with stricter product regulations).
- Phase 2: Expansion to edibles, extracts, and topicals.
Key Findings:
- During Phase 1, there was a 25.8% immediate reduction in cannabis-related ED visits among men with schizophrenia.
- Women also saw a significant 18.5% drop in mental health–related ED visits.
- During Phase 2, no significant changes were observed.
In short: when legalisation rolled out with tighter controls, people with schizophrenia were less likely to end up in emergency care due to cannabis or mental health issues.
Why Would Legalisation Reduce Emergencies?
The researchers suggest that legalisation – when done properly – improves the quality and safety of cannabis products.
Before legalisation, many users (especially vulnerable groups like schizophrenia patients) relied on unregulated, underground cannabis, which can be contaminated, super-potent, or mislabeled.
After legalisation, access to lab-tested, standardised, and regulated products likely reduced risky consumption patterns.
As the authors put it:
“Regulatory measures accompanying legalization could enhance the quality and safety of cannabis products, potentially leading to fewer adverse health outcomes in vulnerable patient populations.“
But Isn’t Cannabis Linked to Psychosis?
Yes. But it’s complicated.
There is strong evidence that heavy, frequent use of high-THC cannabis – particularly starting young – can increase the risk of developing psychotic disorders.
However, these studies don’t prove causation and most of them focus on illicit cannabis markets, where products are often extremely high in THC and users have little idea what they’re consuming.
In contrast, regulated cannabis markets provide:
- Lower-risk product options (e.g., balanced CBD:THC ratios).
- Clear labeling.
- Quality control standards.
- Educational campaigns promoting responsible use.
In fact, many researchers argue that legalisation could reduce harm by allowing people to make safer choices.
This Ontario study suggests that when schizophrenia patients have access to safer cannabis, some negative outcomes – like emergency mental health episodes – actually decline.
Not Everyone Agrees
It’s worth mentioning that other research has found concerning signals after legalisation.
For example, a 2022 study in Ontario saw an increase in cannabis-related psychosis ED visits following legalization (Myran et al., 2022). Though that study looked at the general population, not specifically people with schizophrenia.
It’s a reminder that context matters:
- Who is using?
- What are they using?
- How is the market regulated?
The Bigger Picture: Thoughtful Legalisation Matters
This study highlights a key point often missed in cannabis debates:
It’s not just about whether cannabis is legal — it’s about how legalisation is implemented.
Strict quality control.
Clear product information.
Public education about risks and safer use.
Easy access to balanced, lower-potency options.
These factors might be the difference between legalisation improving public health or making things worse.
Final Thoughts: A More Nuanced Conversation
Cannabis and schizophrenia will always be a sensitive topic. But the Ontario study shows that knee-jerk fear narratives don’t tell the whole truth.
When legalisation is done right, it can create safer environments. Especially for vulnerable groups.
At High & Polite, we believe in nuance, honesty, and keeping you informed with the real science.
Because real change starts with real understanding.
📩 Want more clear-eyed cannabis updates?
Sign up for our newsletter for trusted news, product reviews, and cultural commentary straight to your inbox.
[Subscribe now]
